A Northwestern Medicine study has uncovered a signaling process that regulates the inflammation that damages organs in autoimmune diseases.
Browsing: Scientific Advances
Studying patients with a rare form of dementia called primary progressive aphasia has given scientists a new understanding of the way the brain comprehends language.
In two recent studies, the lab of Ramille Shah, PhD, assistant professor in Surgery, developed new methods to create viable biomaterials for 3-D printing, expanding the tools available to scientists to build a vast array of functional artificial tissues and organs.
A new study reveals the biochemical mechanisms underlying kidney hypertrophy. The findings were published in a paper coauthored by Eric G. Neilson, MD, vice president for Medical Affairs and Lewis Landsberg Dean.
Northwestern Medicine scientists, inspired by treatments used by traditional healers in Nigeria, have synthesized four new chemical compounds that may lead to therapies for psychiatric disorders.
David Gius, MD, PhD, professor in Radiation Oncology and Pharmacology, collaborated with University of Chicago scientists on a study identifying a natural compound that activates the protein SIRT3, a potential target for breast cancer, cardiac conditions and other diseases.
Two independent pathways in the human brain evaluate the identity and the value of expected outcomes, according to a Northwestern Medicine study that used appetizing odors to examine brain activity.
Northwestern Medicine scientists are leading a research team that will study a pair of identical twins to determine how living in space for long durations affects the human body.
Northwestern Medicine scientists have identified mechanisms behind desmosomes, important junctions that bind cells together, helping to explain how some skin and heart diseases develop.
Northwestern Medicine scientists have developed a method to systematically explore diverse natural resources, allowing them to quickly identify thousands of compounds from bacteria that have potential to become new pharmaceuticals.